ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,632Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 1456

$1.47M Total Retail Price of All Prescriptions

Rank: 41 out of 1456

819 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 819 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

18% of this provider’s 819 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 20,933 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 1,286 1,144 1 4
SIMVASTATIN 1,173 999 2 2
AMLODIPINE BESYLATE 697 610 3 1
OMEPRAZOLE 613 525 4 5
FLUTICASONE PROPIONATE 495 370 5 28
HYDROCHLOROTHIAZIDE 484 399 6 10
FUROSEMIDE 451 375 7 7
DIOVAN 444 386 8 35
LOSARTAN POTASSIUM 415 344 9 16
POTASSIUM CHLORIDE 404 330 10 15
NEXIUM 403 350 11 23
METFORMIN HCL 396 334 12 8
LISINOPRIL 391 299 13 3
CITALOPRAM HBR 376 335 14 22
BENAZEPRIL HCL 355 331 15 57
HYDROCODONE-ACETAMINOPHEN 346 293 S3 16 6
CYMBALTA 338 256 17 52
ZOLPIDEM TARTRATE 301 258 18 14
DIOVAN HCT 296 277 19 59
DONEPEZIL HCL 254 254 20 29
BYSTOLIC 246 216 21 102
AMLODIPINE BESYLATE-BENAZEPRIL 225 186 22 61
METOPROLOL SUCCINATE 219 211 23 19
GABAPENTIN 214 167 24 13
CLOPIDOGREL 213 196 25 32
MELOXICAM 209 188 26 30
METOPROLOL TARTRATE 207 198 27 12
ALLOPURINOL 195 192 28 31
ATENOLOL 194 185 29 18
SYNTHROID 192 182 30 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 187 107 31 24
ADVAIR DISKUS 186 139 32 63
GLIPIZIDE 186 149 32 53
WARFARIN SODIUM 184 164 34 21
FAMOTIDINE 182 154 35 45
PREDNISONE 177 133 36 42
SINGULAIR 175 124 37 83
CRESTOR 171 146 38 26
CIPROFLOXACIN HCL 169 153 39 58
BENICAR 163 163 40 130
PLAVIX 162 152 41 46
GEMFIBROZIL 159 128 42 117
PROAIR HFA 156 88 43 69
GLIPIZIDE XL 156 146 43 134
PREMARIN 155 136 R 45 99
CARVEDILOL 151 137 46 20
LANTUS 142 96 47 50
ESCITALOPRAM OXALATE 140 113 48 74
INSULIN SYRINGE 140 113 48 64
CEFUROXIME 140 109 48 138
GLIPIZIDE ER 139 115 51 86
NAMENDA 136 136 52 38
LEVOFLOXACIN 133 112 53 79
DIGOXIN 133 132 53 62
ZETIA 131 120 55 71
SYMBICORT 130 97 56 157
ALENDRONATE SODIUM 124 124 57 36
MONTELUKAST SODIUM 124 82 57 135
ATORVASTATIN CALCIUM 124 119 57 11
ACETAMINOPHEN-CODEINE 117 100 S3 60 174
ROPINIROLE HCL 112 103 61 90
PEN NEEDLE 110 102 62 131
TAMSULOSIN HCL 108 108 63 34
EXFORGE 105 97 64 211
NITROFURANTOIN MONO-MACRO 104 98 65 182
SERTRALINE HCL 101 90 66 25
AZITHROMYCIN 99 84 67 44
LANTUS SOLOSTAR 97 87 68 120
CYCLOBENZAPRINE HCL 97 67 R 68 66
PRAVASTATIN SODIUM 91 47 70 9
PANTOPRAZOLE SODIUM 87 81 71 43
NIASPAN 87 87 71 127
TRILIPIX 87 81 71 188
KOMBIGLYZE XR 85 70 74 397
CELEBREX 84 65 75 88
NAPROXEN 84 79 75 100
LOSARTAN-HYDROCHLOROTHIAZIDE 84 69 75 41
SPIRIVA 82 80 78 75
LYRICA 80 51 79 91
FLUCONAZOLE 78 64 80 148
MECLIZINE HCL 76 73 81 101
ENALAPRIL MALEATE 73 60 82 87
VERAPAMIL ER 73 73 82 82
TRICOR 72 57 84 92
ONGLYZA 72 45 84 202
BENICAR HCT 71 65 86 160
HYDROXYZINE HCL 70 36 R 87 164
RANITIDINE HCL 70 48 87 27
BENAZEPRIL-HYDROCHLOROTHIAZIDE 70 70 87 177
AMOX TR-POTASSIUM CLAVULANATE 69 54 90 118
COLCRYS 68 60 91 122
VENLAFAXINE HCL ER 67 66 92 89
FINASTERIDE 67 67 92 110
TRIAMCINOLONE ACETONIDE 67 54 92 158
TRAZODONE HCL 67 43 92 47
HUMALOG 64 48 96 196
METOCLOPRAMIDE HCL 59 45 97 125
NORTRIPTYLINE HCL 59 50 97 242
TRAMADOL HCL 59 51 97 17
TRIAMTERENE-HCTZ 56 40 100 49
LOVASTATIN 56 47 100 40
NOVOLOG 56 32 100 104
TRAMADOL HCL-ACETAMINOPHEN 55 54 103 139
LANSOPRAZOLE 55 32 103 137
CHLORTHALIDONE 55 53 103 152
MUPIROCIN 54 47 106 224
CLOTRIMAZOLE-BETAMETHASONE 53 52 107 163
FENOFIBRATE 53 27 107 56
BUPROPION HCL SR 52 52 109 185
LUNESTA 52 52 109 276
ACTOS 51 51 111 115
PRIMIDONE 50 48 112 243
AMITRIPTYLINE HCL 50 41 R 112 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.